Health Technology Assessment in Primary Care and Mental Health (PRISMA)
Research Program
Where we are
Parc Sanitari Sant Joan de Déu
Professional network profiles
Related websites
Parc Sanitari Sant Joan de Déu The Research Group Health Technology Assessment in Primary Care and Mental Health (PRISMA) at Institut de Recerca Sant Joan de Déu (IRSJD) is recognized by the Generalitat de Catalunya as a consolidated research group (SGR1503). The group is made up of an interdisciplinary team of researchers and clinical professionals from disciplines including psychiatry, pharmacy, psychology, nursing, and family and community medicine. Its members actively participate in leading research networks and consortia, including the Centre d'Investigació Biomèdica en Xarxa d'Epidemiologia i Salut Pública (CIBERESP), the Xarxa de Recerca en Cronicitat, Atenció Primària i Promoció de la Salut (RICAPPS), and TECSAM (Red per la Innovació de Noves Tecnologies en Salut Mental).
The group's mission is to generate scientific evidence that contributes to improving people's health and well-being, promote evidence-based decision-making, and foster the sustainability of healthcare systems through the evaluation of health technologies, services, and interventions, particularly in the fields of primary care and mental health.
The group was established in 2003 with the aim of conducting research in the field of mental disorders managed in community settings. Between 2003 and 2005, it was part of the IRYSS (Investigación en Resultados de Salud y Servicios Sanitarios) network and subsequently joined the national Recerca en Activitats Preventives i Promoció de la Salut (redIAPP) network between 2007 and 2021. Since 2018, it has participated in the Centre d'Investigació Biomèdica en Xarxa d'Epidemiologia i Salut Pública (CIBERESP - CB16/02/00322) and, since 2022, it has been part of the Xarxa per a la Investigació en Cronicitat, Atenció Primària i Promoció de la Salut (RICAPPS - RD24/0005/0007), networks funded by the Instituto de Salud Carlos III.
Research lines
- Patient Participation, Patient Experience, and Person-Centred Research. Principal Investigator: Dr. Montserrat Gil-Girbau.
- Evaluation of Healthcare Services, Technologies, and Health Outcomes. Principal Investigator: Dr. Antoni Serrano-Blanco.
Scientific objectives
- To improve people's health and well-being through the development and evaluation of innovative, evidence-based interventions.
- To generate knowledge on the effectiveness, implementation, and value of complex interventions in real-world clinical and community practice settings.
- To co-design, together with key stakeholders, effective, efficient, and sustainable preventive and therapeutic strategies.
- To reduce inequalities and stigma in mental health through research aimed at transforming healthcare services and society.
- To promote participatory methodologies that incorporate the voices of patients, healthcare professionals, caregivers, and communities throughout all stages of the research process.
Area/Field of expertise
PRISMA focuses its activities on transforming models of care and healthcare organizations by incorporating public participation, patient experience, and co-creation as cross-cutting pillars of its research. Through a multidisciplinary approach, the group evaluates healthcare services and technologies to generate evidence that supports decision-making and improves the quality of care, acting as a bridge between knowledge generation and its translation into clinical practice and the organization of healthcare services. In doing so, PRISMA contributes to the development of a more efficient, equitable, sustainable, and person-centred healthcare system.
The group brings together professionals with extensive methodological expertise in health economics, quantitative research, qualitative research, and mixed methods. Its research activity is based on the integration of different methodological approaches that combine quantitative techniques-such as Real World Data analysis, studies of medication adherence trajectories, clinical and observational studies, and economic evaluations-with qualitative and participatory methodologies tailored to each study population.
Health economics is a cross-cutting component of the group's research activity, providing tools to assess the efficiency, value, and sustainability of interventions, technologies, and models of care, while contributing to evidence-based decision-making aimed at maximizing health outcomes.
These approaches make it possible to generate robust and relevant evidence while facilitating its implementation in real-world practice and enhancing the impact of research on healthcare delivery, health policies, and decision-making.
Group members
-
Jefe de Grupo Senior
-
Investigador colaborador
-
Investigador
-
Técnico
-
Investigador
-
Investigador
-
Ayudante de investigación
-
Investigador
-
Claudia Macarena Palma Vásquez
Investigador
-
Ayudante de investigación
-
Jefe de Grupo
-
Investigador
-
Investigador
-
Investigador
-
Investigador
-
Rita Fernández Vergel
Investigador colaborador
Last Publications
- Peñarrubia-María MT, Mari Carmen Olmos Palenzuela, Gil MM, Rubio-Valera M, Puig-García M, Guilabert Mora M, López-Pintor E, Rosell EC, Parker LA and Aznar I Pathways to chronic benzodiazepine use: a qualitative study of user and professional perspectives BMC Primary Care . 27(1): .
- Rolduà-Ros J, Vila R, Manuel Abella Villena, Colomer A, Serra C, Corbella-Sotil A, Carmona A, Rubio E, N DC, Butjosa A, Moreno-Poyato AR, Lluch-Canut T, J T, Jiménez-Fernández B and Usall J Factors Influencing Self-Stigma in the First Year of First-Episode Psychosis. Early Intervention in Psychiatry . 20(3): .
- Kobson, B, Hanley, J, Mair, A, Dima AL, Rea, N and Paterson, RE Patients' perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence. International Journal of Clinical Pharmacy . 48(1): 1-16.
Projects
- Project name:
- Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS)
- Leader
- Maria Montserrat Gil Girbau
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0005/0007
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Motius en la cronificació de l’Ús de Benzodiazepines: Estudi Qualitatiu (Estudi B-LONG)
- Leader
- Maria Montserrat Gil Girbau
- Funding entities:
- Provincia San Juan de Dios de España
- Code
- PFNR0207
- Starting - finishing date:
- 2024 - 2025
- Project name:
- M-AES_Estancia en Center of Research in Pharmacoeconomics and Drug utilization (CIRFF) at University of Naples Federico Il
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- MV23/00027
- Starting - finishing date:
- 2024 - 2024
Theses
-
Adaptación al medio penitenciario de hombres con psicosis. Validación de la escala “prison adjustment index” en población masculina con psicosis
- Author
- Cañete Mena, Gustavo Adolfo
- Institution
- UNIVERSIDAD AUTÓNOMA DE BARCELONA
-
Problemas de Adherencia al Inicio de Tratamientos para la Enfermedad Cardiovascular y Diabetes
- Author
- Vilaplana Carnerero, Carles
- Institution
- UNIVERSIDAD DE BARCELONA
-
El problema de la no iniciación del tratamiento farmacológico: evaluación con métodos cualitativos
- Author
- Gil Girbau, Maria Montserrat
- Institution
- UNIVERSIDAD DE BARCELONA
News
-
New study reveals that one in four patients who start treatment with benzodiazepines uses them for a long time
According to the data analyzed, 27.1% of patients who receive a new prescription for this type of drug end up becoming long-term users after three months, and 14.5% are still so after six months.
-
More than 6% of Europeans suffer from depression
Dr. Antoni Serrano (Institut de Recerca Sant Joan de Déu) participates in a study led by King's College London and the Hospital del Mar Medical Research Institute where the prevalence of depression among the population of more than 27 European countries has been studied.
-
Research identifies six groups in the population more susceptible to the impact of the pandemic
Dr. Belén Arranz, Dr. Judith Usall i Rodié and Dr. Antoni Serrano from the Institut de Recerca Sant Joan de Déu participate in the project COM-COVID, leds by Dr. Cristina Vilaplana from the Germans Trias i Pujol Research Institute.
More activities
-
Defensa tesi doctoral: Marina Fuente Moreno
Casanova Street, 143
-
Defensa tesi doctoral: Carmen Corral Partearroyo
Universitat Autònoma de Barcelona (UAB)
